Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_216cb51c4fc33597e8bd304b3982f849 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ad09153a01732821cdbc279f2f8ea3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a92ffb5fece467ffc2d32be36b289af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f283c5f048fc8b3d293f94132c3f4564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b03493f54bcb8aaf0e23152a2779ccd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f000f8bdbc15d81e298af1319466e5e0 |
publicationDate |
2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017056492-A1 |
titleOfInvention |
Porcine parvovirus |
abstract |
The present invention relates to a novel porcine parvovirus, to proteins of the virus and to vaccines based upon the virus and proteins thereof. The invention also relates to DNA fragments comprising a gene of the virus and to DNA vaccines based upon genes of the virus. Further the invention relates to antibodies that are reactive with the novel virus and to diagnostic tests for the detection of the virus or antibodies against the virus. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113557302-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021055383-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398773-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108315401-A |
priorityDate |
2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |